2021 Q3 Form 10-Q Financial Statement

#000161417821000211 Filed on September 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $98.12M $88.06M
YoY Change 11.43% 21.67%
Cost Of Revenue $26.62M $21.98M
YoY Change 21.07% 14.09%
Gross Profit $71.51M $66.07M
YoY Change 8.23% 24.42%
Gross Profit Margin 72.88% 75.03%
Selling, General & Admin $79.42M $75.52M
YoY Change 5.16% 6.8%
% of Gross Profit 111.06% 114.31%
Research & Development $18.50M $14.79M
YoY Change 25.1% 16.57%
% of Gross Profit 25.87% 22.38%
Depreciation & Amortization $4.000M $3.000M
YoY Change 33.33% 76.47%
% of Gross Profit 5.59% 4.54%
Operating Expenses $97.92M $90.31M
YoY Change 8.43% 8.29%
Operating Profit -$26.41M -$24.24M
YoY Change 8.96% -19.99%
Interest Expense $158.0K $154.0K
YoY Change 2.6% 94.94%
% of Operating Profit
Other Income/Expense, Net -$741.0K -$423.0K
YoY Change 75.18% 108.37%
Pretax Income -$27.31M -$24.77M
YoY Change 10.24% -15.18%
Income Tax $300.0K $300.0K
% Of Pretax Income
Net Earnings -$27.59M -$25.12M
YoY Change 9.86% -14.25%
Net Earnings / Revenue -28.12% -28.52%
Basic Earnings Per Share -$0.22 -$0.21
Diluted Earnings Per Share -$0.22 -$0.21
COMMON SHARES
Basic Shares Outstanding 126.9M shares 118.4M shares
Diluted Shares Outstanding 126.9M shares 118.4M shares

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $240.5M $223.3M
YoY Change 7.7% -18.56%
Cash & Equivalents $240.5M $223.3M
Short-Term Investments
Other Short-Term Assets $16.19M $20.40M
YoY Change -20.63% 47.83%
Inventory
Prepaid Expenses
Receivables $59.11M $53.12M
Other Receivables $0.00 $0.00
Total Short-Term Assets $349.2M $325.9M
YoY Change 7.15% -5.6%
LONG-TERM ASSETS
Property, Plant & Equipment $80.29M $64.07M
YoY Change 25.32% 350.91%
Goodwill $4.800M $4.800M
YoY Change 0.0% 4.35%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.127M $5.209M
YoY Change 17.62% 184.64%
Total Long-Term Assets $219.5M $205.7M
YoY Change 6.71% 26.28%
TOTAL ASSETS
Total Short-Term Assets $349.2M $325.9M
Total Long-Term Assets $219.5M $205.7M
Total Assets $568.7M $531.7M
YoY Change 6.98% 4.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.497M $19.12M
YoY Change -50.32% 79.6%
Accrued Expenses $40.25M $29.20M
YoY Change 37.85% -2.67%
Deferred Revenue $165.4M $147.2M
YoY Change 12.36% 19.97%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $228.9M $208.3M
YoY Change 9.86% 20.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.601M $5.858M
YoY Change -4.39% 265.44%
Total Long-Term Liabilities $5.601M $5.858M
YoY Change -4.39% 265.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $228.9M $208.3M
Total Long-Term Liabilities $5.601M $5.858M
Total Liabilities $352.2M $338.1M
YoY Change 4.16% 19.47%
SHAREHOLDERS EQUITY
Retained Earnings -$562.6M -$477.0M
YoY Change 17.94% 36.53%
Common Stock $134.0K $126.0K
YoY Change 6.35% 5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.90M $11.90M
YoY Change 0.0% 0.0%
Treasury Stock Shares 6.505M shares 6.505M shares
Shareholders Equity $216.6M $193.5M
YoY Change
Total Liabilities & Shareholders Equity $568.7M $531.7M
YoY Change 6.98% 4.63%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$27.59M -$25.12M
YoY Change 9.86% -14.25%
Depreciation, Depletion And Amortization $4.000M $3.000M
YoY Change 33.33% 76.47%
Cash From Operating Activities -$32.61M -$15.64M
YoY Change 108.53% 36.71%
INVESTING ACTIVITIES
Capital Expenditures -$3.098M -$18.78M
YoY Change -83.5% 418.78%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.098M -$18.78M
YoY Change -83.5% -207.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.978M 6.690M
YoY Change -40.54% 21.2%
NET CHANGE
Cash From Operating Activities -32.61M -15.64M
Cash From Investing Activities -3.098M -18.78M
Cash From Financing Activities 3.978M 6.690M
Net Change In Cash -31.73M -27.73M
YoY Change 14.44% -339.88%
FREE CASH FLOW
Cash From Operating Activities -$32.61M -$15.64M
Capital Expenditures -$3.098M -$18.78M
Free Cash Flow -$29.52M $3.140M
YoY Change -1040.0% -140.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001614178
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38056
dei Entity Registrant Name
EntityRegistrantName
YEXT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8059722
dei Entity Address Address Line1
EntityAddressAddressLine1
61 Ninth Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10011
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
994-3900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
YEXT
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127845122 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240490000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230411000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2786000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2528000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59110000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97455000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16192000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4842000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17993000 USD
CY2021Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
33428000 USD
CY2021Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
30325000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
349220000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
376184000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80287000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80344000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
99972000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
104844000 USD
CY2021Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
27916000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22692000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
4764000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
458000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
767000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6127000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6316000 USD
CY2021Q3 us-gaap Assets
Assets
568744000 USD
CY2021Q1 us-gaap Assets
Assets
595989000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49307000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54186000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
165377000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
191810000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14191000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14165000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
228875000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
260161000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117689000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
123584000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5601000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5009000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
352165000 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q1 us-gaap Liabilities
Liabilities
388754000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134305353 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130494513 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127800019 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123989179 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
134000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
130000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
788149000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
733933000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2769000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2422000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-562568000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-517345000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
11905000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
11905000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
216579000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
207235000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
568744000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
595989000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98124000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88055000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173406000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
26615000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
21984000 USD
us-gaap Cost Of Revenue
CostOfRevenue
48469000 USD
us-gaap Cost Of Revenue
CostOfRevenue
43168000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
71509000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
66071000 USD
us-gaap Gross Profit
GrossProfit
141647000 USD
us-gaap Gross Profit
GrossProfit
130238000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
58578000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
56049000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
113744000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114569000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18500000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14788000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32357000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29166000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20843000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39190000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39932000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19474000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
97921000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
90311000 USD
us-gaap Operating Expenses
OperatingExpenses
185291000 USD
us-gaap Operating Expenses
OperatingExpenses
183667000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26412000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24240000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-43644000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-53429000 USD
CY2021Q3 us-gaap Interest Income Operating
InterestIncomeOperating
4000 USD
CY2020Q3 us-gaap Interest Income Operating
InterestIncomeOperating
47000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
10000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
515000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
158000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
154000 USD
us-gaap Interest Expense
InterestExpense
290000 USD
us-gaap Interest Expense
InterestExpense
291000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-741000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-423000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-827000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-507000 USD
CY2021Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-27307000 USD
CY2020Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-24770000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-44751000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-53712000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
285000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
346000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
472000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
628000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27592000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-25116000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45223000 USD
us-gaap Net Income Loss
NetIncomeLoss
-54340000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126906937 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126906937 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118411758 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118411758 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126152602 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126152602 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117519214 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117519214 shares
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2250000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
347000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
917000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27600000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22866000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44876000 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53423000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
201212000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16516000 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74417000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2782000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-94692000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
207235000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14385000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3817000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36018000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
347000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45223000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
216579000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45223000 USD
us-gaap Net Income Loss
NetIncomeLoss
-54340000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7933000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5187000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
909000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2316000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
35000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34602000 USD
yext Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
4619000 USD
yext Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
6827000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
371000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
344000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37618000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26001000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1681000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7929000 USD
yext Increase Decrease In Deferred Sales Commissions
IncreaseDecreaseInDeferredSalesCommissions
8442000 USD
yext Increase Decrease In Deferred Sales Commissions
IncreaseDecreaseInDeferredSalesCommissions
-3726000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-15000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1191000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-711000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7010000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-26337000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-31377000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5634000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3744000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
650000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2805000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2449000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16295000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10555000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40055000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223347000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10555000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40055000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14439000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6651000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
263000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
654000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3409000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3667000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17585000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9664000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
600000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1857000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10079000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44829000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230411000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268176000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240490000 USD
CY2021Q3 yext Number Of Service And Application Providers
NumberOfServiceAndApplicationProviders
200 Provider
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of those financial statements and the reported amounts of revenue and expense during the reporting period. These estimates include, but are not limited to, the standalone selling prices of performance obligations, the incremental borrowing rate associated with lease liabilities, the useful life of capitalized costs to obtain revenue contracts, income taxes, and the valuation and assumptions underlying stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the financial position and results of operations.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operatingSegment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operatingSegment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operatingSegment
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskCertain financial instruments that could be exposed to a concentration of credit risk include cash and cash equivalents and accounts receivable. The Company deposits its cash with financial institutions, and such deposits, at times, may exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Collateral is not required for accounts receivable.
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98124000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
88055000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173406000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
165400000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
132600000 USD
CY2021Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
700000 USD
CY2021Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
200000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
341600000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
323800000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
351800000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
4800000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4800000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operatingSegment
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingUnit
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
500000 USD
us-gaap Depreciation
Depreciation
7600000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
4000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
800000 USD
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
CY2021Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
108458000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
100941000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28171000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20597000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80287000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80344000 USD
CY2021Q3 yext Employee Stock Purchase Plan Withholdings Liability Current
EmployeeStockPurchasePlanWithholdingsLiabilityCurrent
2821000 USD
CY2021Q1 yext Employee Stock Purchase Plan Withholdings Liability Current
EmployeeStockPurchasePlanWithholdingsLiabilityCurrent
3230000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
3000000 USD
us-gaap Depreciation
Depreciation
4900000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9497000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12974000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17423000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16780000 USD
CY2021Q3 yext Accrued Fees To Service Providers Current
AccruedFeesToServiceProvidersCurrent
2997000 USD
CY2021Q1 yext Accrued Fees To Service Providers Current
AccruedFeesToServiceProvidersCurrent
3671000 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2820000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2202000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13749000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15329000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49307000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54186000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
700000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4500000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8871890 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y11M8D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
81906000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1471011 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7813 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.80
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7393066 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M21D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
43098000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7322361 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.17
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
43003000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7035440 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M26D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
42593000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9700000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13100000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20402000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17230000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34602000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
162800000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1000000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
500000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
800000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
207235000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12111000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3817000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15288000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
355000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17631000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
221175000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2274000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20730000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27592000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
216579000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
201212000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1896000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3743000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17617000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1333000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-29224000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
193911000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4751000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17752000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2250000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-25116000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
193548000 USD
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 yext Common Stock Numberof Votes Per Share
CommonStockNumberofVotesPerShare
1 vote
CY2021Q1 yext Common Stock Numberof Votes Per Share
CommonStockNumberofVotesPerShare
1 vote
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6505334 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6505334 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
11900000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
11900000 USD
yext Line Of Credit Facility Covenant Terms Required Trailing Revenue Growth Period
LineOfCreditFacilityCovenantTermsRequiredTrailingRevenueGrowthPeriod
4 quarter
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14200000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117700000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
100000000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
us-gaap Operating Lease Payments
OperatingLeasePayments
9500000 USD
us-gaap Lease Cost
LeaseCost
13300000 USD
us-gaap Lease Cost
LeaseCost
13100000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
8502000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
10944000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
379000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
784000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
4408000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1338000 USD
us-gaap Lease Cost
LeaseCost
13289000 USD
us-gaap Lease Cost
LeaseCost
13066000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Remainder Of Fiscal Year
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsRemainderOfFiscalYear
9726000 USD
CY2021Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
15275000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due Year One
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDueYearOne
19147000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
12304000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due Year Two
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDueYearTwo
18849000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
5931000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due Year Three
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDueYearThree
18295000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1939000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due Year Four
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDueYearFour
18991000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
1840000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due Year Five And Thereafter
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDueYearFiveAndThereafter
92759000 USD
CY2021Q3 yext Contractual Obligation Due In Fifth Year And Thereafter
ContractualObligationDueInFifthYearAndThereafter
1939000 USD
CY2021Q3 yext Lessee Operating Lease Including Lease Not Yet Commenced Payments Due
LesseeOperatingLeaseIncludingLeaseNotYetCommencedPaymentsDue
177767000 USD
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
39228000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27592000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-25116000 USD
us-gaap Net Income Loss
NetIncomeLoss
-45223000 USD
us-gaap Net Income Loss
NetIncomeLoss
-54340000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126906937 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126906937 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118411758 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118411758 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126152602 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126152602 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117519214 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117519214 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18842171 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21286193 shares

Files In Submission

Name View Source Status
0001614178-21-000211-index-headers.html Edgar Link pending
0001614178-21-000211-index.html Edgar Link pending
0001614178-21-000211.txt Edgar Link pending
0001614178-21-000211-xbrl.zip Edgar Link pending
ex311sect302certceoq2fy22.htm Edgar Link pending
ex312sect302certcfoq2fy22.htm Edgar Link pending
ex321sect906certceoq2fy22.htm Edgar Link pending
ex322sect906certcfoq2fy22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yext-20210731.htm Edgar Link pending
yext-20210731.xsd Edgar Link pending
yext-20210731_cal.xml Edgar Link unprocessable
yext-20210731_def.xml Edgar Link unprocessable
yext-20210731_g1.jpg Edgar Link pending
yext-20210731_htm.xml Edgar Link completed
yext-20210731_lab.xml Edgar Link unprocessable
yext-20210731_pre.xml Edgar Link unprocessable